Cigna Q4 Adjusted EPS $4.96 Beats $4.86 Estimate, Sales $45.75B Beat $45.71B Estimate

Cigna (NYSE:CI) reported quarterly earnings of $4.96 per share which beat the analyst consensus estimate of $4.86 by 2.06 percent. This is a 3.98 percent increase over earnings of $4.77 per share from the same period

Cigna (NYSE:CI) reported quarterly earnings of $4.96 per share which beat the analyst consensus estimate of $4.86 by 2.06 percent. This is a 3.98 percent increase over earnings of $4.77 per share from the same period last year. The company reported quarterly sales of $45.75 billion which beat the analyst consensus estimate of $45.71 billion by 0.09 percent. This is a 0.14 percent increase over sales of $45.69 billion the same period last year.

Total
0
Shares
Related Posts
Read More

Janssen Announced Phase 3 MAGNITUDE Study Shows Trend Toward Improvement In Overall Survival in Patients With Metastatic Castration Resistant Prostate Cancer With BRCA Alterations Treated With Niraparib And Abirateron + Prednisone

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis (FA) of the Phase 3 MAGNITUDE study, in which a pre-planned multivariate analysis [MVA] showed niraparib, a

JNJ